- Q1 2024 FibroGen Inc Earnings Call TranscriptMay 06, 2024$1.15Earnings
- Q4 2023 FibroGen Inc Earnings Call TranscriptFeb 26, 2024$1.79 (-7.46%)Earnings
- FibroGen Inc KOL Investor Event Series Part I (Virtual) TranscriptFeb 13, 2024
- Q3 2023 FibroGen Inc Earnings Call TranscriptNov 06, 2023$0.62071 (-3.54%)Earnings
- Q2 2023 FibroGen Inc Earnings Call TranscriptAug 07, 2023$1.75 (-8.74%)Earnings
- FibroGen Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- FibroGen Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Q1 2023 FibroGen Inc Earnings Call TranscriptMay 08, 2023$17.28Earnings
- Q4 2022 FibroGen Inc Earnings Call TranscriptFeb 27, 2023$22.32Earnings
- FibroGen Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 08, 2022
- Q3 2022 FibroGen Inc Earnings Call TranscriptNov 07, 2022$16.4 (+2.82%)Earnings
- Q2 2022 FibroGen Inc Earnings Call TranscriptAug 08, 2022$14.35 (-0.62%)Earnings
- Q1 2022 FibroGen Inc Earnings Call TranscriptMay 09, 2022$8.74Earnings
- Q4 2021 FibroGen Inc Earnings Call TranscriptFeb 28, 2022$14.51Earnings
- Q3 2021 FibroGen Inc Earnings Call TranscriptNov 09, 2021$11.9 (-2.86%)Earnings
- Q2 2021 FibroGen Inc Earnings Call TranscriptAug 09, 2021$13.26Earnings
- FibroGen Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- FibroGen Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 04, 2021
- FibroGen Inc Annual Shareholders Meeting TranscriptMay 26, 2021
- FibroGen Inc at Bank of America Global Research Healthcare Conference (Virtual) - Fireside Chat TranscriptMay 13, 2021
- Q1 2021 FibroGen Inc Earnings Call TranscriptMay 10, 2021$19.49 (-4.95%)Earnings
- FibroGen Inc Provides Additional Information on Roxadustat - Conference Call TranscriptApr 06, 2021
- FibroGen Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 02, 2021
- Q4 2020 FibroGen Inc Earnings Call TranscriptMar 01, 2021$51.04 (+3.39%)Earnings
- FibroGen Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- FibroGen Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 19, 2020
- Q3 2020 FibroGen Inc Earnings Call TranscriptNov 05, 2020$45.91Earnings
- FibroGen Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- FibroGen Inc at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2020
- Q2 2020 FibroGen Inc Earnings Call TranscriptAug 06, 2020$42.34Earnings
- FibroGen Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2020
- FibroGen Inc Annual Shareholders Meeting TranscriptJun 04, 2020
- FibroGen Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2020
- FibroGen Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Q1 2020 FibroGen Inc Earnings Call TranscriptMay 07, 2020$43.38Earnings
- Q4 2019 FibroGen Inc Earnings Call TranscriptMar 02, 2020$43.38Earnings
- FibroGen Inc at Leerink Global Healthcare Conference TranscriptFeb 25, 2020
- Q3 2019 FibroGen Inc Earnings Call TranscriptNov 11, 2019$38.88Earnings
- Q2 2019 FibroGen Inc Earnings Call TranscriptAug 08, 2019$54.05Earnings
- FibroGen Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 12, 2019
- Q1 2019 FibroGen Inc Earnings Call TranscriptMay 09, 2019$54.05Earnings
- Q4 2018 FibroGen Inc Earnings Call TranscriptFeb 27, 2019$49.95Earnings
FibroGen Inc at Jefferies Healthcare Conference Transcript
Thank you, everyone, for joining us at our next session. I am very happy to have the CEO of FibroGen up here on the stage with us, CEO Enrique Conterno. It's great to have you here.
Obviously, FibroGen is at an exciting and critical juncture for the company. They have been obviously executing on roxadustat across the commercial business with its partner AstraZeneca in China. And obviously, they have been executing on the pipeline with pamrevlumab, of which there are multiple Phase 3 readouts coming. And one was recently, which we've talked about, but certainly more to come.
So I would love, Enrique, maybe just to make some opening comments about FibroGen with a focus specifically, first on pamrevlumab. I think everybody would love to hear about how you're thinking about the recent news for pamrevlumab this week and obviously, how to think about the upcoming IPF study and the other readouts that are coming for pamrevlumab.
Very good. Now, thank you very much for the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)